Mvua I-Gene Select
Natural health product licensed in Canada
- Other names
- Mvua Eyegene, Mvua Genevit, Mvua OCCvit
- Licence holder
- Amzen Health Inc.
- NPN or DIN-HM
- 80084994
- Status
- Active licence
- Licence date
- 8 May 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 25 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 500 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Gluconate de zinc | 25 mg | 25,000 µg |
| Lutéine Source : Tagetes erecta - Fleur | 10 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 500 mg | 500,000 µg |
| Vitamine E Source : d-alpha tocophérol Potency : 400 UI | 268 mg AT | Not calculated |
| Cuivre Source : Tagetes erecta - Fleur | 2 mg | 2,000 µg |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Fleur | 2 mg | Not calculated |
Non-medicinal ingredients
Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in wound healing. Helps to maintain immune function. Source of/An antioxidant that protects the fat in body tissues from oxidation. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps in energy metabolism and tissue formation. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism. Helps to maintain healthy bones, hair, nail and/or skin. Helps to produce and repair connective tissue. Helps to form red blood cells. Helps to maintain normal iron transport in the body. Source of/An antioxidant for the maintenance of good health/eye health. Helps to maintain/support eyesight in certain conditions (associated with sunlight damage) such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have cardiovascular disease or diabetes, consult a health care practitioner prior to use. If you have cancer, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80084994
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.